Keshav Deo
vice president
Infectious Diseases
Cempra
India
Biography
Dr. Keshav Deo currently serves as vice president of the Chemical Research Division of Wockhardt Research Center,Aurangabad, India. Dr. Deo has held positions within the research and development divisions of various Indian pharmaceutical companies. He began his career with Lupin, followed by Tata Pharma, Sun Pharma, Dai-Ichi Laboratories, Ranbaxy and Alembic Limited. Dr. Deo is a member of several national and international chemical research societies and scientific advisory boards. He is recognized as a supervisor for the Ph.D. degree programs of several Indian universities. Globally, he has filed more than 120 patent applications. Prior to beginning his professional career with Lupin, Dr. Deo earned his Ph.D. from Central Drug Research Institute in Lucknow, India, in 1989, under the direction of Dr. D.S. Bhakuni. He earned his Master’s degree from Agra University, Agra in 1985. His research interests include chemo and region selective reductions, asymmetric catalysis and insightful process development of significant active pharmaceutical ingredients.
Research Interest
Dr. Keshav Deo currently serves as vice president of the Chemical Research Division of Wockhardt Research Center,Aurangabad, India. Dr. Deo has held positions within the research and development divisions of various Indian pharmaceutical companies. He began his career with Lupin, followed by Tata Pharma, Sun Pharma, Dai-Ichi Laboratories, Ranbaxy and Alembic Limited. Dr. Deo is a member of several national and international chemical research societies and scientific advisory boards. He is recognized as a supervisor for the Ph.D. degree programs of several Indian universities. Globally, he has filed more than 120 patent applications. Prior to beginning his professional career with Lupin, Dr. Deo earned his Ph.D. from Central Drug Research Institute in Lucknow, India, in 1989, under the direction of Dr. D.S. Bhakuni. He earned his Master’s degree from Agra University, Agra in 1985. His research interests include chemo and region selective reductions, asymmetric catalysis and insightful process development of significant active pharmaceutical ingredients.
